|Bid||1.40 x 200|
|Ask||5.86 x 600|
|Day's Range||3.10 - 3.15|
|52 Week Range||2.41 - 7.39|
|PE Ratio (TTM)||-0.42|
|Earnings Date||May 10, 2017 - May 15, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||2.00|
Categories: Yahoo FinanceGet free summary analysis Cesca Therapeutics, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Cesca Therapeutics, Inc. – Haemonetics Corporation, Cerus Corporation, Stryker Corporation, Cytori Therapeutics, Inc. and Span-America Medical Systems, Inc. (HAE-US, CERS-US, SYK-US, CYTX-US and SPAN-US) that have also reported ... Read more (Read more...)
RANCHO CORDOVA, Calif., May 18, 2017-- Cesca Therapeutics Inc., a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that Dr. Dalip Sethi, senior ...
RANCHO CORDOVA, Calif., May 11, 2017-- Cesca Therapeutics Inc., a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced financial and operating ...